Cargando…
Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting
The therapeutic scope of antibody and nonantibody protein scaffolds is still prohibitively limited against intracellular drug targets. Here, we demonstrate that the Alphabody scaffold can be engineered into a cell-penetrating protein antagonist against induced myeloid leukemia cell differentiation p...
Autores principales: | Pannecoucke, Erwin, Van Trimpont, Maaike, Desmet, Johan, Pieters, Tim, Reunes, Lindy, Demoen, Lisa, Vuylsteke, Marnik, Loverix, Stefan, Vandenbroucke, Karen, Alard, Philippe, Henderikx, Paula, Deroo, Sabrina, Baatz, Franky, Lorent, Eric, Thiolloy, Sophie, Somers, Klaartje, McGrath, Yvonne, Vlierberghe, Pieter Van, Lasters, Ignace, Savvides, Savvas N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997521/ https://www.ncbi.nlm.nih.gov/pubmed/33771865 http://dx.doi.org/10.1126/sciadv.abe1682 |
Ejemplares similares
-
Structural basis of IL-23 antagonism by an Alphabody protein scaffold
por: Desmet, Johan, et al.
Publicado: (2014) -
P326: A DUAL ROLE FOR PSIP1 IN T-ALL
por: Demoen, Lisa, et al.
Publicado: (2023) -
Engineering and crystal structure of a monomeric FLT3 ligand variant
por: Pannecoucke, Erwin, et al.
Publicado: (2021) -
Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
por: Pieters, Tim, et al.
Publicado: (2019) -
In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
por: Van Trimpont, Maaike, et al.
Publicado: (2022)